• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

Celyad Oncology Announces March 2021 Conference Schedule

March 1, 2021 By Celyad Oncology

Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following virtual investor conferences in March 2021:

H.C. Wainwright Global Life Sciences Conference

Date: Tuesday, March 9 – Wednesday, March 10, 2021

Time: 7:00 a.m. ET / 1:00 p.m. CET

Webcast: A webcast of the presentation will be available in the Events section of the Celyad Oncology website for approximately 90 days from the start of the event.

BioCapital Europe

Date: Thursday, March 11, 2021

Time: 9:50 a.m. ET / 3:50 p.m. CET

Download press release(s)
Communiqué de presse
Press Release

Filed Under: Uncategorized

Footer

  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use